Sort by
Keyphrases
Adult HIV Patients
50%
Antiretroviral Therapy
50%
Apolipoprotein A-I (ApoA-I)
41%
Apolipoprotein B (Apo B)
50%
AST-ALT
33%
Atorvastatin
50%
Carotid Intima-media Thickness (cIMT)
37%
Central Vein
50%
CMV Seropositivity
50%
Collagen I
50%
Collagen III
50%
COVID-19
89%
COVID-19 Laboratories
50%
COVID-19 Patients
50%
Cupping Therapy
50%
Cytoglobin
50%
Cytomegalovirus
50%
Cytomegalovirus Infection
50%
Hijamah
50%
Histological Properties
50%
HIV Patients
58%
Hypoxia-inducible factor-1α (HIF-1α)
41%
Hypoxic Condition
50%
Immune Activation
37%
Indonesia
58%
Jatropha Curcas
100%
Jatropha Seeds
75%
K417N
50%
Keloid
50%
Leydig Cells
42%
Lipid Profile
50%
Lipoproteins
50%
Liver
50%
Male Rats
58%
National Laboratories
30%
Older Adults
50%
Omicron Variant
56%
Oral Pemphigus Vulgaris
50%
Pemphigus Vulgaris
50%
Randomized Placebo-controlled Trial
50%
SARS-CoV-2 Omicron
50%
Seed Extract
100%
Single nucleotide Polymorphism
50%
Spermatocyte
42%
Subclinical Atherosclerosis
50%
T Cells
50%
Tangerang
50%
Therapeutic Dilemma
50%
Therapeutic Effect
50%
World Health Organization
50%
Medicine and Dentistry
Antiretroviral Therapy
50%
Apolipoprotein
50%
Apolipoprotein A
20%
Apolipoprotein B
50%
Atherosclerosis
50%
Atorvastatin
50%
Azathioprine
16%
CD8 Antigen
9%
Cell Count
21%
Collagen Synthesis
12%
Contact Examination
12%
Contraceptive Agent
16%
COVID-19
100%
COVID-19 Diagnostics
18%
Cytomegalovirus
50%
Cytomegalovirus Antibody
9%
Cytomegalovirus Infection
58%
Desquamation
16%
Dyslipidemia
10%
Fibrosis
12%
High Density Lipoprotein Cholesterol
10%
Human Immunodeficiency Virus
100%
Informed Consent
8%
Intima-Media Thickness
25%
Keloid
50%
Leydig Cell
41%
Male Contraceptive
16%
Memory T Cell
9%
Messenger RNA
18%
Methylprednisolone
16%
Omicron Coronavirus Variant
50%
Oral Medicine
16%
Oral Submucous Fibrosis
16%
Palate
8%
Pemphigus vulgaris
50%
Placebo
50%
Procollagen
18%
Seminiferous Tubule
50%
Severe Acute Respiratory Syndrome Coronavirus 2
50%
Single Nucleotide Polymorphism
50%
Spermatocyte
50%
Spermiogenesis
16%
Statin
25%
Surveillance System
18%
T Cell
50%
T-Helper Cell
13%
Testes
16%
Therapy Effect
50%
Virus
14%
Wound
25%
